1
2
3
4
5
6
7
8
9
10
11
12
13 | On 10/01/2022, at 9:30am Licensing Program Analyst (LPA) Arielle Pascua arrived at the facility unannounced to follow up on the allegation above. LPA Pascua was greeted by Sophia Patterson and was told to call the Facility Designated Administrator(FDA) to let them know that CCL was present at this time. At 9:35am, LPA Pascua met with FDA, Simone-Pierre Jerome and explained the purpose of the visit. The purpose of the visit was to deliver complaint findings of the allegation above. Current census was 5.
During the course of this investigation, LPA Pascua reviewed facility documents and conducted 3 staff interviews. Based on an interview with FDA, Jerome it was learned that the individual was interviewed and went through the process of a background check in order to work at the facility. Shortly after, FDA, Jerome stated that she recieved a letter that they needed to provide more paperwork in order to clear the background check. FDA, stated that she did not allow the individual at any time to work at the facility until she was cleared by the department. FDA, Jerome stated that they never completed the paperwork and therefore could not come back and work for the facility. |